
HEMOCLOTâ„¢ Quanti-V-L
Price:
$385.00
Product DescriptionFor In Vitro Diagnostic Use.
HEMOCLOT™ Quanti VL is the ONLY quantitative APC Resistance assay available. Clotting method using Factor V-deficient plasma substrate that eliminates interference from other coagulation variables. Calculates a normalized APC Sensitivity Ratio (APC-SR) that discriminates: normal (APC-SR >2.0), heterozygous FV Leiden (APC-SR ~1.5), and homozygous FV Leiden (APC-SR ~1.0) — without genetic testing. For thrombophilia screening: FV Leiden is the most common inherited thrombophilia (3-8% of Caucasians). Heterozygous = 5x VTE risk; homozygous = 50-80x VTE risk. Also detects acquired APC resistance (pregnancy, OCP, lupus anticoagulant). FDA 510(k) cleared. CE-IVD. Product Characteristics
Product Components
|
Product Applications
Quantitative measurement of FV-L, resistant to the action of Activated Protein C, for diagnosing patients carrying the R506Q FV mutation (Factor V-Leiden), or any FV mutant resistant to APC.
|